An intervention trial for patients with hyperglycaemia and acute coronary syndrome: How effective is lifestyle advice?

Primary Care Cardiovascular Journal

Volumn 6, Issue 2, 2013, Pages 72-75

  Krebs, Jeremy D ^a   Van Wissen, Kim A ^b   Harding, Scott A ^c   Ward, Margaret A ^d   Marra, Berni ^e   Page, Rachel A ^b  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

^c CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^d Endocrine Diabetes and Research Centre   (New Zealand)

^e National Primary Care Network   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGONIST; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84883609995     PISSN: 17565138     EISSN: 17565146     Source Type: Journal    
DOI: 10.3132/pccj.2013.008     Document Type: Article

References (21)

1. Guerrero-Romero F, Rodriguez-Moran M. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 2006;36:796-802. (Pubitemid 44569968)
2. Bartnik M, Norhammar A, Ryden L. Hyperglycaemia and cardiovascular disease. J Intern Med 2007;262:145-56. (Pubitemid 47087633)
3. Ishihara M, Inoue I, Kawagoe T et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance. Eur Heart J 2006;27:2413-19. (Pubitemid 44522147)
4. Norhammar A, Tenerz Å, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4. (Pubitemid 34694020)
5. Wallander M, Bartnik M, Efendic S et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 2005;48:2229-35. (Pubitemid 41618911)
6. Bartnik M, Rydén L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880-90. (Pubitemid 39452604)
7. Krebs JD, Robinson GM, Smith RB, Toomath RJ. Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1c. NZ Med J 2000;113:379-81.
8. Harding SA, Anscombe R, Weatherall M, Prasad S, Krebs J. Abnormal glucose metabolism and features of the metabolic syndrome are common in patients presenting for elective cardiac catherization. Intern Med J 2006;36:759-64. (Pubitemid 44691183)
9. Knowler WC, Barrett-Connor E, Fowler SE et al. Reducing the incidence of type 2 diabetes with lifestyle intervention and metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
10. DPP Research group. The influence of age and the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Bio Sci Med 2006;61:1075-81.
11. Ahmad LA, Crandall JP. Type 2 diabetes prevention: a review. Clin Diabetes 2010;28:53-9.
12. Ministry of Health Diabetes and Cardiovascular Disease Quality Improvement Plan, Wellington: Ministry of Health, 2008.
13. New Zealand Guidelines Group. New Zealand Primary Care Handbook 2012. 3rd ed. Wellington: New Zealand Guidelines Group; 2012.
14. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers. A systematic review. Arch Intern Med 2008;168:1950-60.
15. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev 2004;13:2012-22.
16. Caterson ID, Finer N, Coutinho W et al. on behalf of the SCOUT Investigators. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab 2012;14:523-30.
17. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart 2009;95:468-75.
18. Franco OH, de Laet C, Peeters A et al. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 2005;165:2355-60. (Pubitemid 41640847)
19. Preston C, Cheater F, Baker R, Hearnshaw H. Left in limbo: patients' views on care across the primary/secondary interface. Qual Health Care 1999;8:16-21. (Pubitemid 29161507)
20. Berendsen AJ, Kuiken A, Benneker W HGM et al. How do general practitioners and specialists value their mutual communication? A survey. BMC Health Serv Res 2009;9:143-51.
21. Kronish IM, Rieckmann N, Halm EA et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006; 21:1178-83. (Pubitemid 44506872)